|
COPYRIGHT 2006 Asia Pulse Pty Ltd
SYDNEY, March 28 Asia Pulse - Drug developer Peptech Ltd (ASX:PTD) says developing antibodies is the way into the future, even though biotechnology licensing deals are sometimes "like pulling a rabbit out of a hat".
Speaking at a luncheon in Sydney Monday, Peptec chief executive officer John Chiplin said antibodies are hot property and the company is...
Read the full article for free courtesy of your local library.
|